Hodgkin's lymphoma.
Yung L, Linch D.
Lancet. 2003 Mar 15;361(9361):943-51. doi: 10.1016/S0140-6736(03)12777-8.
Hodgkin's lymphoma.
Cole S, Dunne K.
Nurs Stand. 2004 Jan 21-27;18(19):46-52; quiz 54-5. doi: 10.7748/ns2004.01.18.19.46.c3531.
Hodgkin's lymphoma.
Tsang RW, Hodgson DC, Crump M.
Curr Probl Cancer. 2006 May-Jun;30(3):107-58. doi: 10.1016/j.currproblcancer.2006.04.001.
Hodgkin's lymphoma in adults.
Townsend W, Linch D.
Lancet. 2012 Sep 1;380(9844):836-47. doi: 10.1016/S0140-6736(12)60035-X. Epub 2012 Jul 25.
[Hodgkin's lymphoma].
Jyrkkiio S, Mokka M, Vasala K.
Duodecim. 2014;130(9):913-20.
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?
Longo DL, Armitage JO.
N Engl J Med. 2022 Jul 28;387(4):370-372. doi: 10.1056/NEJMe2207639. Epub 2022 Jul 13.
Hodgkin's lymphoma (relapsed or refractory): autologous stem cell therapy.
Rahemtulla A, Terpos E.
BMJ Clin Evid. 2015 Oct 26;2015:2404.
Histopathology of Hodgkin's lymphoma.
Eberle FC, Mani H, Jaffe ES.
Cancer J. 2009 Mar-Apr;15(2):129-37. doi: 10.1097/PPO.0b013e31819e31cf.
Cardiovascular effects of Hodgkin's lymphoma: a review of literature.
Jacob A, Thyagarajan B, Kumar MP, Shaikh N, Sharon D.
J Cancer Res Clin Oncol. 2018 Jan;144(1):99-107. doi: 10.1007/s00432-017-2560-x. Epub 2017 Dec 18.
Hodgkin's lymphoma: molecular targets and novel treatment strategies.
Yazbeck V, Georgakis GV, Wedgwood A, Younes A.
Future Oncol. 2006 Aug;2(4):533-51. doi: 10.2217/14796694.2.4.533.
